M3, Inc. (MTHRF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
M3, Inc. (MTHRF) trades at $11.00 with AI Score 48/100 (Grade C). M3, Inc. is a leading Japanese healthcare information services provider, focusing on internet-based solutions for medical professionals. Market cap: $7.34B, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for MTHRF: MTHRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MTHRF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MTHRF: the 1 perspectives are evenly split.
How is this calculated? →M3, Inc. (MTHRF) Healthcare & Pipeline Overview
M3, Inc. stands out in the healthcare information services sector by providing a comprehensive suite of internet-based solutions for medical professionals, including platforms for career development, medical information, and pharmaceutical marketing.
What Is the Investment Thesis for MTHRF?
M3, Inc. has demonstrated a robust financial performance with a market capitalization of $7.34B and a profit margin of 14.0%, supported by a gross margin of 50.0%. The company's diverse revenue streams from its digital platforms and services present significant growth potential, particularly in the expanding healthcare information services market. With ongoing investments in technology and international expansion, M3 is well-positioned to capture a larger share of the market. The company's P/E ratio of 22.0 indicates a healthy valuation relative to its earnings, suggesting that M3 is effectively leveraging its resources for growth. Key growth catalysts include the increasing demand for digital healthcare solutions, the expansion of its international presence, and the continuous enhancement of its service offerings. However, potential risks such as regulatory changes and competition from established players in the healthcare sector must be monitored closely.
Based on FMP financials and quantitative analysis
MTHRF Key Highlights
- Market Cap of $7.34B reflects strong market positioning in healthcare information services.
- Profit Margin of 14.0% indicates effective cost management and operational efficiency.
- Gross Margin of 50.0% exceeds industry averages, showcasing robust service profitability.
- P/E Ratio of 22.0 suggests a reasonable valuation given the company's growth prospects.
- Beta of 0.47 indicates lower volatility compared to the broader market.
Who Are MTHRF's Competitors?
MTHRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| RCDTF Recordati Industria Chimica e Farmaceutica S.p.A. | $58.00 | +0.00% | $11.80B | 54 |
| BDUUF Bangkok Dusit Medical Services Public Company Limited | $0.60 | -6.25% | $9.54B | 52 |
| SHPMF Shanghai Pharmaceuticals Holding Co., Ltd | $1.46 | +0.00% | $8.46B | 45 |
| WILLF Demant A/S | $38.78 | -3.60% | $8.18B | 52 |
| GIFLF Grifols, S.A. | $10.45 | +0.00% | $7.11B | 52 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MTHRF's Key Strengths?
- Diverse portfolio of digital platforms tailored for healthcare professionals.
- Strong market presence in Japan with expansion into international markets.
- High gross margin indicating effective cost management.
- Established relationships with healthcare professionals and pharmaceutical companies.
What Are MTHRF's Weaknesses?
- Dependency on the Japanese market for a significant portion of revenue.
- Limited brand recognition outside of Asia compared to global competitors.
- Potential regulatory challenges in international markets.
- High competition in the digital healthcare space.
What Are the Growth Opportunities for MTHRF?
- Expansion of Digital Platforms: M3, Inc. is poised to enhance its digital platform offerings, particularly m3.com and AskDoctors, aiming to increase user engagement and subscription rates. The global telemedicine market is expected to grow from $45 billion in 2020 to $175 billion by 2026, providing a substantial opportunity for M3 to capture a larger audience and increase revenue streams.
- International Market Penetration: M3's international services, such as MDLinx and Doctorsnetuk, present significant growth potential. As healthcare systems worldwide increasingly adopt digital solutions, M3 aims to expand its footprint in major markets like the U.S. and Europe, targeting a market size of over $100 billion by 2025 in healthcare IT.
- Career Solutions for Healthcare Professionals: The m3com CAREER service is designed to support the career development of doctors and pharmacists. With the healthcare workforce continuously evolving, M3 can capitalize on the growing demand for career support services, projected to grow at a CAGR of 10% through 2025.
- Pharmaceutical Marketing Services: M3's engagement in sales and marketing for pharmaceuticals and medical devices positions it to benefit from the increasing demand for innovative marketing solutions in the healthcare sector. The global market for pharmaceutical marketing services is expected to reach $45 billion by 2025, offering M3 a lucrative avenue for growth.
- Electronic Medical Records Development: M3's involvement in the development and maintenance of electronic medical records aligns with the industry's shift towards digitalization. The electronic health records market is projected to grow from $29 billion in 2020 to $50 billion by 2025, providing M3 with opportunities to enhance its service offerings and capture additional market share.
What Opportunities Does MTHRF Have?
- Growing demand for digital healthcare solutions globally.
- Expansion into emerging markets with increasing healthcare needs.
- Development of new services to enhance user engagement on platforms.
- Partnerships with pharmaceutical companies for innovative marketing solutions.
What Threats Does MTHRF Face?
- Intense competition from established healthcare information service providers.
- Rapid technological changes requiring continuous innovation.
- Regulatory changes impacting operations in different countries.
- Economic downturns affecting healthcare spending.
What Are MTHRF's Competitive Advantages?
- Established brand recognition in the Japanese healthcare market.
- Comprehensive suite of digital platforms catering to various healthcare needs.
- Strong relationships with healthcare professionals and pharmaceutical companies.
- Expertise in navigating regulatory environments in multiple countries.
- Diverse revenue streams reducing dependency on any single service.
What Does MTHRF Do?
M3, Inc. was founded in 2000 and is headquartered in Tokyo, Japan. Initially incorporated as So-netM3, Inc., the company rebranded to M3, Inc. in January 2010. M3 primarily focuses on delivering internet-based services to physicians and healthcare professionals through a diverse range of digital platforms. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. The flagship platform, m3.com, serves as an exclusive online portal providing healthcare information to its members. MR-kun allows doctors to access continuous updates and content from the m3com system, while QOL-kun offers non-medical life-enhancement information. For public inquiries, M3 operates AskDoctors, where registered medical experts address health-related questions. Internationally, M3 extends its services through MDLinx for U.S. medical professionals and Doctorsnetuk in the U.K., supporting pharmaceutical companies and providing drug information databases across Europe. Additionally, M3 supports career development for healthcare professionals through its m3com CAREER service. Beyond these platforms, M3 engages in various activities within the medical and pharmaceutical sectors, including sales and marketing for pharmaceuticals and medical devices, development of electronic medical records, and management consulting for medical facilities. This multifaceted approach positions M3 as a key player in the healthcare information services industry, catering to both healthcare professionals and the pharmaceutical sector.
What Products and Services Does MTHRF Offer?
- Provide internet-based services tailored for healthcare professionals.
- Operate m3.com, a members-only portal for healthcare information.
- Facilitate career development for doctors and pharmacists through m3com CAREER.
- Conduct surveys and provide consulting services for medical facilities.
- Engage in sales and marketing for pharmaceuticals and medical devices.
- Manage clinical trial facilities and home-visit nursing services.
How Does MTHRF Make Money?
- Generate revenue through subscription services for healthcare professionals.
- Offer marketing and consulting services to pharmaceutical companies.
- Provide career development resources for medical professionals.
- Engage in the development and maintenance of electronic medical records.
- Conduct surveys and research services for healthcare institutions.
What Industry Does MTHRF Operate In?
The healthcare information services industry is experiencing significant growth, driven by the increasing reliance on digital solutions for healthcare delivery. The global healthcare IT market is projected to reach $390 billion by 2024, with a CAGR of approximately 15%. M3, Inc. is strategically positioned within this expanding market, leveraging its comprehensive digital platforms to cater to healthcare professionals and pharmaceutical companies. The competitive landscape includes notable players such as Recordati Industria Chimica e Farmaceutica S.p.A. and Shanghai Pharmaceuticals Holding Co., Ltd., highlighting the need for continuous innovation and service enhancement.
Who Are MTHRF's Key Customers?
- Healthcare professionals including doctors and pharmacists.
- Pharmaceutical companies seeking marketing and consulting services.
- Medical institutions requiring electronic medical records and consulting.
- General public seeking health information through AskDoctors.
- International medical professionals using MDLinx and Doctorsnetuk.
ROE 12%Key Financial Metrics
Return on equity for M3, Inc. stands at 12.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.7%, showing how much profit it generates from its asset base. MTHRF trades at a trailing price-to-earnings ratio of 22.04, roughly in line with the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.73 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.1%, the inverse of the P/E and a quick read on earnings relative to price.
M3, Inc. (MTHRF) Valuation Context
Valued at $7.34B, MTHRF is classified as a mid-cap stock. Relative to its peer group, MTHRF's quantitative score of 48/100 is roughly in line with the peer average of 51/100.
Company Profile
M3, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Tokyo, JP. The company is led by CEO Itaru Tanimura. MTHRF has traded publicly since 2014.
F-Score 4/9Financial Health
M3, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.88 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project M3, Inc. revenue of about $356.88B for fiscal 2026, with EPS near $75.75. The estimate reflects 13 contributing analysts.
MTHRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Diverse portfolio of digital platforms tailored for healthcare professionals.
- Strong market presence in Japan with expansion into international markets.
- High gross margin indicating effective cost management.
- Established relationships with healthcare professionals and pharmaceutical companies.
Bear Case
- Dependency on the Japanese market for a significant portion of revenue.
- Limited brand recognition outside of Asia compared to global competitors.
- Potential regulatory challenges in international markets.
- High competition in the digital healthcare space.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
MTHRF Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Oct 1, 2019
MTHRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MTHRF.
Price Targets
Wall Street price target analysis for MTHRF.
MTHRF MoonshotScore
What does this score mean?
The MoonshotScore rates MTHRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
MTHRF OTC Market Information
MTHRF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
M3, Inc. Healthcare Stock: Key Questions Answered
What are the key factors to evaluate for MTHRF?
M3, Inc. (MTHRF) holds an AI score of 48/100 (low). P/E: 22.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does MTHRF data refresh on this page?
MTHRF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MTHRF's recent stock price performance?
M3, Inc. (MTHRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse portfolio of digital platforms tailored for healthcare professionals. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MTHRF overvalued or undervalued right now?
M3, Inc. (MTHRF) trades at 22.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MTHRF?
Before investing in M3, Inc. (MTHRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MTHRF to a portfolio?
Key strength of M3, Inc. (MTHRF): Diverse portfolio of digital platforms tailored for healthcare professionals. Weigh rewards against risks and diversify. Not financial advice.
Can I buy fractional shares of MTHRF?
Yes, most major brokerages offer fractional shares of M3, Inc. (MTHRF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MTHRF's earnings and financial reports?
M3, Inc. (MTHRF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for MTHRF earnings announcements is recommended.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.